Weight loss isn’t just cosmetic; it prevents chronic disease, saves money and improves mental and physical well-being.

GLP-1 drugs like semaglutide and tirzepatide show promise in treating obesity, with benefits including weight loss and ...

Ozempic and Mounjaro may also lower your risk of obesity-linked cancer. A study found another potential benefit of the weight loss drugs: lowered risk of chronic conditions.

Objectives To compare the odds of depression in obese and overweight children with that in normal-weight children in the community. Design Systematic review and random-effect meta-analysis of ...

Globally, obesity is on the rise, and it is projected that without immediate action, around a third (746 million) of the world’s children and adolescents will be overweight or obese by 2050.

Objective Overweight and obesity have been shown to be related to multiple chronic conditions, leading to a heavy economic burden on society throughout the world. This study aims to estimate the ...

Obesity medicine is likely heading the way of treatments for high blood pressure or diabetes, with three to five effective options for different types of patients. For example, up to 15% of ...

Researchers from the George Washington University have uncovered promising evidence in an animal study that shows setmelanotide, an FDA-approved medication for a rare genetic obesity disorder, may ...

The FDA determined in December and February, respectively, that the companies could meet demand. Grace periods for the compounding pharmacies expired this spring. Some have already stopped compounding ...

Despite an increase in the prevalence of prescribing, only 0.5% of U.S. adolescents with obesity were prescribed an obesity medication in 2023, according to research published in the June 5 issue ...

Just 0.5% with obesity were prescribed an obesity medication in 2023; 83% of prescriptions received by teens with severe obesity. HealthDay News — Despite an increase in the prevalence of ...